Blue Owl’s Dyal in Talks to Buy Stake in PAI Partners

Blue Owl’s Dyal in Talks to Buy Stake in PAI Partners

Blue Owl Capital’s Dyal Capital arm is in talks to acquire a stake in private equity firm PAI Partners, according to people familiar with the matter. Dyal is in preliminary discussions about the potential purchase of a minority holding in PAI, the people said, asking...
Inflexion exits Pharmaspectra in $100m deal

Inflexion exits Pharmaspectra in $100m deal

Inflexion has exited its investment in Pharmaspectra, a leading global provider of medical affairs data and analytics to the pharmaceutical and biotech industry, to a listed trade buyer. This sale follows strong continued exit momentum for Inflexion with nine exits...
SoftBank steps up asset sales from sinking portfolio

SoftBank steps up asset sales from sinking portfolio

SoftBank is accelerating asset sales after its flagship Vision Fund unit booked nearly $50bn in losses in just six months, but Chief Executive Masayoshi Son faces narrowing options and slumping valuations, analysts said. Son said on Monday that he is in discussions to...